Mitochondrial Disease-Its Impact, Etiology, and Pathology

Current Topics in Developmental Biology

Volumn 77, Issue , 2007, Pages 113-155

  McFarland, R ^a   Taylor, R W ^a   Turnbull, D M ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

MITOCHONDRIAL DNA;

AGING; ANIMAL; CELL RESPIRATION; DISORDERS OF MITOCHONDRIAL FUNCTIONS; GENE EXPRESSION; GENETICS; GENOME; HUMAN; PATHOLOGY; REVIEW;

AGING; ANIMALS; CELL RESPIRATION; DNA, MITOCHONDRIAL; GENE EXPRESSION; GENOME; HUMANS; MITOCHONDRIAL DISEASES;

EID: 33846022731     PISSN: 00702153     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0070-2153(06)77005-3     Document Type: Review

References (206)

1. Agostino A., Valletta L., Chinnery P.F., Ferrari G., Carrara F., Taylor R.W., Schaefer A.M., Turnbull D.M., Tiranti V., and Zeviani M. Mutations of ANT1, Twinkle, and POLG1 in sporadic progressive external ophthalmoplegia (PEO). Neurology 60 (2003) 1354-1356
2. Awadalla P., Eyre-Walker A., and Maynard Smith J. Linkage disequilibrium and recombination in hominid mitochondrial DNA. Science 286 (1999) 2524-2525
3. Ballinger S.W., Shoffner J.M., Hedaya E.V., Trounce I., Polak M.A., Koontz D.A., and Wallace D.C. Maternally transmitted diabetes and deafness associated with a 10.4 kb mitochondrial DNA deletion. Nat. Genet. 1 (1992) 11-15
4. Bataillard M., Chatzoglou E., Rumbach L., Sternberg D., Tournade A., Laforet P., Jardel C., Maisonobe T., and Lombes A. Atypical MELAS syndrome associated with a new mitochondrial tRNA glutamine point mutation. Neurology 56 (2001) 405-407
5. Battersby B.J., Loredo-Osti J.C., and Shoubridge E.A. Nuclear genetic control of mitochondrial DNA segregation. Nat. Genet. 33 (2003) 183-186 Epub 2003 Jan 21
6. Bender A., Krishnan K.J., Morris C.M., Taylor G.A., Reeve A.K., Perry R.H., Jaros E., Hersheson J.S., Betts J., Klopstock T., Taylor R.W., and Turnbull D.M. High levels of mitochondrial DNA deletions in substantia nigra neurons in aging and Parkinson disease. Nat. Genet. 38 (2006) 515-517
7. Biggin A., Henke R., Bennetts B., Thorburn D.R., and Christodoulou J. Mutation screening of the mitochondrial genome using denaturing high-performance liquid chromatography. Mol. Genet. Metab. 84 (2005) 61-74
8. Birch-Machin M.A., and Turnbull D.M. Assaying mitochondrial respiratory complex activity in mitochondria isolated from human cells and tissues. Methods Cell Biol. 65 (2001) 97-117
9. Bogenhagen D.F., and Clayton D.A. Mouse L cell mitochondrial DNA molecules are selected randomly for replication throughout the cell cycle. Cell 11 (1977) 719-727
10. Bogenhagen D.F., and Clayton D.A. Concluding remarks: The mitochondrial DNA replication bubble has not burst. Trends Biochem. Sci. 28 (2003) 404-405
11. Bogenhagen D.F., and Clayton D.A. The mitochondrial DNA replication bubble has not burst. Trends Biochem. Sci. 28 (2003) 357-360
12. Bohlega S., Tanji K., Santorelli F.M., Hirano M., al-Jishi A., and DiMauro S. Multiple mitochondrial DNA deletions associated with autosomal recessive ophthalmoplegia and severe cardiomyopathy. Neurology 46 (1996) 1329-1334
13. Boulet L., Karpati G., and Shoubridge E.A. Distribution and threshold expression of the tRNA(Lys) mutation in skeletal muscle of patients with myoclonic epilepsy and ragged-red fibers (MERRF). Am. J. Hum. Genet. 51 (1992) 1187-1200
14. Bowmaker M., Yang M.Y., Yasukawa T., Reyes A., Jacobs H.T., Huberman J.A., and Holt I.J. Mammalian mitochondrial DNA replicates bidirectionally from an initiation zone. J. Biol. Chem. 278 (2003) 50961-50969 Epub 2003 Sep 23
15. Brierley E.J., Johnson M.A., Lightowlers R.N., James O.F., and Turnbull D.M. Role of mitochondrial DNA mutations in human aging: Implications for the central nervous system and muscle. Ann. Neurol. 43 (1998) 217-223
16. Brown T.A., Cecconi C., Tkachuk A.N., Bustamante C., and Clayton D.A. Replication of mitochondrial DNA occurs by strand displacement with alternative light-strand origins, not via a strand-coupled mechanism. Genes Dev. 19 (2005) 2466-2476
17. Bykhovskaya Y., Mengesha E., Wang D., Yang H., Estivill X., Shohat M., and Fischel-Ghodsian N. Phenotype of non-syndromic deafness associated with the mitochondrial A1555G mutation is modulated by mitochondrial RNA modifying enzymes MTO1 and GTPBP3. Mol. Genet. Metab. 83 (2004) 199-206
18. Calabrese V., Lodi R., Tonon C., D'Agata V., Sapienza M., Scapagnini G., Mangiameli A., Pennisi G., Stella A.M., and Butterfield D.A. Oxidative stress, mitochondrial dysfunction and cellular stress response in Friedreich's ataxia. J. Neurol. Sci. 233 (2005) 145-162
19. Campos Y., Gamez J., Garcia A., Andreu A.L., Rubio J.C., Martin M.A., del Hoyo P., Navarro C., Cervera C., Garesse R., and Arenas J. A new mtDNA mutation in the tRNA(Leu(UUR)) gene associated with ocular myopathy. Neuromuscul. Disord. 11 (2001) 477-480
20. Canafoglia L., Franceschetti S., Antozzi C., Carrara F., Farina L., Granata T., Lamantea E., Savoiardo M., Uziel G., Villani F., Zeviani M., and Avanzini G. Epileptic phenotypes associated with mitochondrial disorders. Neurology 56 (2001) 1340-1346
21. Carrozzo R., Tessa A., Vazquez-Memije M.E., Piemonte F., Patrono C., Malandrini A., Dionisi-Vici C., Vilarinho L., Villanova M., Schagger H., Federico A., Bertini E., et al. The T9176G mtDNA mutation severely affects ATP production and results in Leigh syndrome. Neurology 56 (2001) 687-690
22. Casari G., De Fusco M., Ciarmatori S., Zeviani M., Mora M., Fernandez P., De Michele G., Filla A., Cocozza S., Marconi R., Durr A., Fontaine B., et al. Spastic paraplegia and OXPHOS impairment caused by mutations in paraplegin, a nuclear-encoded mitochondrial metalloprotease. Cell 93 (1998) 973-983
23. Chagnon P., Gee M., Filion M., Robitaille Y., Belouchi M., and Gauvreau D. Phylogenetic analysis of the mitochondrial genome indicates significant differences between patients with Alzheimer disease and controls in a French-Canadian founder population. Am. J. Med. Genet. 85 (1999) 20-30
24. Chang D.D., and Clayton D.A. Precise identification of individual promoters for transcription of each strand of human mitochondrial DNA. Cell 36 (1984) 635-643
25. Chang D.D., and Clayton D.A. Priming of human mitochondrial DNA replication occurs at the light-strand promoter. Proc. Natl. Acad. Sci. USA 82 (1985) 351-355
26. Chang D.D., Hauswirth W.W., and Clayton D.A. Replication priming and transcription initiate from precisely the same site in mouse mitochondrial DNA. EMBO J. 4 (1985) 1559-1567
27. Chinnery P.F., and Samuels D.C. Relaxed replication of mtDNA: A model with implications for the expression of disease. Am. J. Hum. Genet. 64 (1999) 1158-1165
28. Chinnery P.F., Howell N., Lightowlers R., and Turnbull D. Molecular pathology of MELAS and MERRF: The relationship between mutation load and clinical phenotype. Brain 120 (1997) 1713-1721
29. Chinnery P.F., Johnson M.A., Wardell T.M., Singh-Kler R., Hayes C., Brown D.T., Taylor R.W., Bindoff L.A., and Turnbull D.M. The epidemiology of pathogenic mitochondrial DNA mutations. Ann. Neurol. 48 (2000) 188-193
30. Chinnery P.F., Taylor D.J., Brown D.T., Manners D., Styles P., and Lodi R. Very low levels of the mtDNA A3243G mutation associated with mitochondrial dysfunction in vivo. Ann. Neurol. 47 (2000) 381-384
31. Chinnery P.F., Elliott H.R., Patel S., Lambert C., Keers S.M., Durham S.E., McCarthy M.I., Hitman G.A., Hattersley A.T., and Walker M. Role of the mitochondrial DNA 16184-16193 poly-C tract in type 2 diabetes. Lancet 366 (2005) 1650-1651
32. Chomyn A., Enriquez J.A., Micol V., Fernandez-Silva P., and Attardi G. The mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episode syndrome-associated human mitochondrial tRNALeu(UUR) mutation causes aminoacylation deficiency and concomitant reduced association of mRNA with ribosomes. J. Biol. Chem. 275 (2000) 19198-19209
33. Clayton D.A. Replication of animal mitochondrial DNA. Cell 28 (1982) 693-705
34. Clayton D.A. Replication and transcription of vertebrate mitochondrial DNA. Annu. Rev. Cell Biol. 7 (1991) 453-478
35. Clayton D.A. Transcription and replication of animal mitochondrial DNAs. Int. Rev. Cytol. 141 (1992) 217-232
36. Coenen M.J., Antonicka H., Ugalde C., Sasarman F., Rossi R., Heister J.G., Newbold R.F., Trijbels F.J., van den Heuvel L.P., Shoubridge E.A., and Smeitink J.A. Mutant mitochondrial elongation factor G1 and combined oxidative phosphorylation deficiency. N. Engl. J. Med. 351 (2004) 2080-2086
37. Coller H.A., Khrapko K., Bodyak N.D., Nekhaeva E., Herrero-Jiminez P., and Thilly W.G. High frequency of homoplasmic mitochondrial DNA mutations in human tumors can be explained without selection. Nat. Genet. 28 (2001) 147-150
38. D'Aurelio M., Gajewski C.D., Lin M.T., Mauck W.M., Shao L.Z., Lenaz G., Moraes C.T., and Manfredi G. Heterologous mitochondrial DNA recombination in human cells. Hum. Mol. Genet. 13 (2004) 3171-3179 Epub 2004 Oct 20
39. Damian M.S., Seibel P., Reichmann H., Schachenmayr W., Laube H., Bachmann G., Wassill K.H., and Dorndorf W. Clinical spectrum of the MELAS mutation in a large pedigree. Acta Neurol. Scand. 92 (1995) 409-415
40. de Coo I.F., Sistermans E.A., de Wijs I.J., Catsman-Berrevoets C., Busch H.F., Scholte H.R., de Klerk J.B., van Oost B.A., and Smeets H.J. A mitochondrial tRNA(Val) gene mutation (G1642A) in a patient with mitochondrial myopathy, lactic acidosis, and stroke-like episodes. Neurology 50 (1998) 293-295
41. de Lonlay P., Valnot I., Barrientos A., Gorbatyuk M., Tzagoloff A., Taanman J.W., Benayoun E., Chretien D., Kadhom N., Lombes A., de Baulny H.O., Niaudet P., et al. A mutant mitochondrial respiratory chain assembly protein causes complex III deficiency in patients with tubulopathy, encephalopathy and liver failure. Nat. Genet. 29 (2001) 57-60
42. De Meirleir L., Seneca S., Damis E., Sepulchre B., Hoorens A., Gerlo E., Garcia Silva M.T., Hernandez E.M., Lissens W., and Van Coster R. Clinical and diagnostic characteristics of complex III deficiency due to mutations in the BCS1L gene. Am. J. Med. Genet. A 121 (2003) 126-131
43. Deschauer M., Wieser T., Neudecker S., Lindner A., and Zierz S. Mitochondrial 3243 A→G mutation (MELAS mutation) associated with painful muscle stiffness. Neuromuscul. Disord. 9 (1999) 305-307
44. DiMauro S., and Schon E.A. Mitochondrial DNA mutations in human disease. Am. J. Med. Genet. 106 (2001) 18-26
45. Ekstrand M.I., Falkenberg M., Rantanen A., Park C.B., Gaspari M., Hultenby K., Rustin P., Gustafsson C.M., and Larsson N.G. Mitochondrial transcription factor A regulates mtDNA copy number in mammals. Hum. Mol. Genet. 13 (2004) 935-944 Epub 2004 Mar 11
46. Elpeleg O., Miller C., Hershkovitz E., Bitner-Glindzicz M., Bondi-Rubinstein G., Rahman S., Pagnamenta A., Eshhar S., and Saada A. Deficiency of the ADP-forming succinyl-CoA synthase activity is associated with encephalomyopathy and mitochondrial DNA depletion. Am. J. Hum. Genet. 76 (2005) 1081-1086 . Epub 2005 Apr 22
47. Elson J.L., Andrews R.M., Chinnery P.F., Lightowlers R.N., Turnbull D.M., and Howell N. Analysis of European mtDNAs for recombination. Am. J. Hum. Genet. 68 (2001) 145-153
48. Engelgau M.M., Geiss L.S., Saaddine J.B., Boyle J.P., Benjamin S.M., Gregg E.W., Tierney E.F., Rios-Burrows N., Mokdad A.H., Ford E.S., Imperatore G., and Narayan K.M. The evolving diabetes burden in the United States. Ann. Intern. Med. 140 (2004) 945-950
49. Enriquez J.A., Chomyn A., and Attardi G. MtDNA mutation in MERRF syndrome causes defective aminoacylation of tRNA(Lys) and premature translation termination. Nat. Genet. 10 (1995) 47-55
50. Excoffier L., and Yang Z. Substitution rate variation among sites in mitochondrial hypervariable region I of humans and chimpanzees. Mol. Biol. Evol. 16 (1999) 1357-1368
51. Falkenberg M., Gaspari M., Rantanen A., Trifunovic A., Larsson N.G., and Gustafsson C.M. Mitochondrial transcription factors B1 and B2 activate transcription of human mtDNA. Nat. Genet. 31 (2002) 289-294
52. Fang W., Huang C.C., Lee C.C., Cheng S.Y., Pang C.Y., and Wei Y.H. Ophthalmologic manifestations in MELAS syndrome. Arch. Neurol. 50 (1993) 977-980
53. Farina L., Chiapparini L., Uziel G., Bugiani M., Zeviani M., and Savoiardo M. MR findings in Leigh syndrome with COX deficiency and SURF-1 mutations. Am. J. Neuroradiol. 23 (2002) 1095-1100
54. Fernandez-Silva P., Enriquez J.A., and Montoya J. Replication and transcription of mammalian mitochondrial DNA. Exp. Physiol. 88 (2003) 41-56
55. Ferrari G., Lamantea E., Donati A., Filosto M., Briem E., Carrara F., Parini R., Simonati A., Santer R., and Zeviani M. Infantile hepatocerebral syndromes associated with mutations in the mitochondrial DNA polymerase-gammaA. Brain 128 (2005) 723-731 Epub 2005 Feb 2
56. Filosto M., Mancuso M., Vives-Bauza C., Vila M.R., Shanske S., Hirano M., Andreu A.L., and DiMauro S. Lack of paternal inheritance of muscle mitochondrial DNA in sporadic mitochondrial myopathies. Ann. Neurol. 54 (2003) 524-526
57. Fisher R.P., Topper J.N., and Clayton D.A. Promoter selection in human mitochondria involves binding of a transcription factor to orientation-independent upstream regulatory elements. Cell 50 (1987) 247-258
58. Fliss M.S., Usadel H., Caballero O.L., Wu L., Buta M.R., Eleff S.M., Jen J., and Sidransky D. Facile detection of mitochondrial DNA mutations in tumors and bodily fluids. Science 287 (2000) 2017-2019
59. Gabaldon T., and Huynen M.A. Shaping the mitochondrial proteome. Biochim. Biophys. Acta 1659 (2004) 212-220
60. Gaspari M., Falkenberg M., Larsson N.G., and Gustafsson C.M. The mitochondrial RNA polymerase contributes critically to promoter specificity in mammalian cells. EMBO J. 23 (2004) 4606-4614 Epub 2004 Nov 4
61. Gerbitz K.-D., van den Ouweland J.M.W., Maasen J.A., and Jaksch M. Mitochondrial diabetes: A review. Biochim. Biophys. Acta 1271 (1995) 253-260
62. Goto Y., Nonaka I., and Horai S. A mutation in the tRNA(Leu)(UUR) gene associated with the MELAS subgroup of mitochondrial encephalomyopathies. Nature 348 (1990) 651-653
63. Goto Y., Nonaka I., and Horai S. A new mtDNA mutation associated with mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes (MELAS). Biochim. Biophys. Acta 1097 (1991) 238-240
64. Goto Y., Tojo M., Tohyama J., Horai S., and Nonaka I. A novel point mutation in the mitochondrial tRNA(Leu)(UUR) gene in a family with mitochondrial myopathy. Ann. Neurol. 31 (1992) 672-675
65. Goto Y., Tsugane K., Tanabe Y., Nonaka I., and Horai S. A new point mutation at nucleotide pair 3291 of the mitochondrial tRNA(Leu(UUR)) gene in a patient with mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS). Biochem. Biophys. Res. Commun. 202 (1994) 1624-1630
66. Griggs R.C., and Karpati G. Muscle pain, fatigue, and mitochondriopathies. N. Engl. J. Med. 341 (1999) 1077-1078
67. Grohmann K., Amairic F., Crews S., and Attardi G. Failure to detect "cap" structures in mitochondrial DNA-coded poly(A)-containing RNA from HeLa cells. Nucleic Acids Res. 5 (1978) 637-651
68. Gu M., Cooper J.M., Taanman J.W., and Schapira A.H. Mitochondrial DNA transmission of the mitochondrial defect in Parkinson's disease. Ann. Neurol. 44 (1998) 177-186
69. Guan M.X., Fischel-Ghodsian N., and Attardi G. Nuclear background determines biochemical phenotype in the deafness-associated mitochondrial 12S rRNA mutation. Hum. Mol. Genet. 10 (2001) 573-580
70. Guenthard J., Wyler F., Fowler B., and Baumgartner R. Cardiomyopathy in respiratory chain disorders. Arch. Dis. Child. 72 (1995) 223-226
71. Hammans S.R., Sweeney M.G., Brockington M., Lennox G.G., Lawton N.F., Kennedy C.R., Morgan-Hughes J.A., and Harding A.E. The mitochondrial DNA transfer RNA(Lys)A→G(8344) mutation and the syndrome of myoclonic epilepsy with ragged red fibres (MERRF). Relationship of clinical phenotype to proportion of mutant mitochondrial DNA. Brain 116 (1993) 617-632
72. Hammans S.R., Sweeney M.G., Hanna M.G., Brockington M., Morgan-Hughes J.A., and Harding A.E. The mitochondrial DNA transfer RNALeu(UUR) A→G(3243) mutation. A clinical and genetic study. Brain 118 (1995) 721-734
73. Hanna M.G., Nelson I.P., Morgan-Hughes J.A., and Harding A.E. Impaired mitochondrial translation in human myoblasts harbouring the mitochondrial DNA tRNA lysine 8344 A→G (MERRF) mutation: Relationship to proportion of mutant mitochondrial DNA. J. Neurol. Sci. 130 (1995) 154-160
74. Hao R., Yao Y.N., Zheng Y.G., Xu M.G., and Wang E.D. Reduction of mitochondrial tRNALeu(UUR) aminoacylation by some MELAS-associated mutations. FEBS Lett. 578 (2004) 135-139
75. Harding A.E., Riordan-Eva P., and Govan G.G. Mitochondrial DNA diseases: Genotype and phenotype in Leber's hereditary optic neuropathy. Muscle Nerve 3 (1995) S82-S84
76. Harman D. Free radical theory of aging. Mutat. Res. 275 (1992) 257-266
77. He L., Chinnery P.F., Durham S.E., Blakely E.L., Wardell T.M., Borthwick G.M., Taylor R.W., and Turnbull D.M. Detection and quantification of mitochondrial DNA deletions in individual cells by real-time PCR. Nucleic Acids Res. 30 (2002) e68
78. He L., Luo L., Proctor S.J., Middleton P.G., Blakely E.L., Taylor R.W., and Turnbull D.M. Somatic mitochondrial DNA mutations in adult-onset leukaemia. Leukemia 17 (2003) 2487-2491
79. Helgason A., Yngvadottir B., Hrafnkelsson B., Gulcher J., and Stefansson K. An Icelandic example of the impact of population structure on association studies. Nat. Genet. 37 (2005) 90-95
80. Herrnstadt C., Elson J.L., Fahy E., Preston G., Turnbull D.M., Anderson C., Ghosh S.S., Olefsky J.M., Beal M.F., Davis R.E., and Howell N. Reduced-median-network analysis of complete mitochondrial DNA coding-region sequences for the major African, Asian, and European haplogroups. Am. J. Hum. Genet. 70 (2002) 1152-1171
81. Hirano M., Silvestri G., Blake D.M., Lombes A., Minetti C., Bonilla E., Hays A.P., Lovelace R.E., Butler I., Bertorini T.E., Threlkeld A.B., Mitsumoto H., et al. Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE): Clinical, biochemical, and genetic features of an autosomal recessive mitochondrial disorder. Neurology 44 (1994) 721-727
82. Holt I.J., Harding A.E., Petty R.K., and Morgan-Hughes J.A. A new mitochondrial disease associated with mitochondrial DNA heteroplasmy. Am. J. Hum. Genet. 46 (1990) 428-433
83. Holt I.J., Lorimer H.E., and Jacobs H.T. Coupled leading- and lagging-strand synthesis of mammalian mitochondrial DNA. Cell 100 (2000) 515-524
84. Hudson G., Keers S., Yu Wai Man P., Griffiths P., Huoponen K., Savontaus M.L., Nikoskelainen E., Zeviani M., Carrara F., Horvath R., Karcagi V., Spruijt L., et al. Identification of an X-chromosomal locus and haplotype modulating the phenotype of a mitochondrial DNA disorder. Am. J. Hum. Genet. 77 (2005) 1086-1091 Epub 2005 Oct 11
85. Huoponen K. Leber hereditary optic neuropathy: Clinical and molecular genetic findings. Neurogenetics 3 (2001) 119-125
86. Huttenlocher P.R., Solitare G.B., and Adams G. Infantile diffuse cerebral degeneration with hepatic cirrhosis. Arch. Neurol. 33 (1976) 186-192
87. Jackson M.J., Schaefer J.A., Johnson M.A., Morris A.A.M., Turnbull D.M., and Bindoff L.A. Presentation and clinical investigation of mitochondrial respiratory chain disease. Brain 118 (1995) 339-357
88. 2 are associated with a distinct form of hypertrophic cardiomyopathy and cytochrome c oxidase deficiency. Hum. Mol. Genet. 9 (2000) 795-801
89. Jeronimo C., Nomoto S., Caballero O.L., Usadel H., Henrique R., Varzim G., Oliveira J., Lopes C., Fliss M.S., and Sidransky D. Mitochondrial mutations in early stage prostate cancer and bodily fluids. Oncogene 20 (2001) 5195-5198
90. Jin H., May M., Tranebjaerg L., Kendall E., Fontan G., Jackson J., Subramony S.H., Arena F., Lubs H., Smith S., Stevenson R., Schwartz C., et al. A novel X-linked gene, DDP, shows mutations in families with deafness (DFN-1), dystonia, mental deficiency and blindness. Nat. Genet. 14 (1996) 177-180
91. Jones J.B., Song J.J., Hempen P.M., Parmigiani G., Hruban R.H., and Kern S.E. Detection of mitochondrial DNA mutations in pancreatic cancer offers a "mass"-ive advantage over detection of nuclear DNA mutations. Cancer Res. 61 (2001) 1299-1304
92. Jun A.S., Brown M.D., and Wallace D.C. A mitochondrial DNA mutation at nucleotide pair 14459 of the NADH dehydrogenase subunit 6 gene associated with maternally inherited Leber hereditary optic neuropathy and dystonia. Proc. Natl. Acad. Sci. USA 91 (1994) 6206-6210
93. Kaukonen J., Juselius J.K., Tiranti V., Kyttala A., Zeviani M., Comi G.P., Keranen S., Peltonen L., and Suomalainen A. Role of adenine nucleotide translocator 1 in mtDNA maintenance. Science 289 (2000) 782-785
94. Khogali S.S., Mayosi B.M., Beattie J.M., McKenna W.J., Watkins H., and Poulton J. A common mitochondrial DNA variant associated with susceptibility to dilated cardiomyopathy in two different populations. Lancet 357 (2001) 1265-1267
95. King M.P., Koga Y., Davidson M., and Schon E.A. Defects in mitochondrial protein synthesis and respiratory chain activity segregate with the tRNA(Leu(UUR)) mutation associated with mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes. Mol. Cell. Biol. 12 (1992) 480-490
96. Kirby D.M., McFarland R., Ohtake A., Dunning C., Ryan M.T., Wilson C., Ketteridge D., Turnbull D.M., Thorburn D.R., and Taylor R.W. Mutations of the mitochondrial ND1 gene as a cause of MELAS. J. Med. Genet. 41 (2004) 784-789
97. Kirches E., Krause G., Warich-Kirches M., Weis S., Schneider T., Meyer-Puttlitz B., Mawrin C., and Dietzmann K. High frequency of mitochondrial DNA mutations in glioblastoma multiforme identified by direct sequence comparison to blood samples. Int. J. Cancer 93 (2001) 534-538
98. Kleiner L., and Sherman J. Leber's hereditary optic neuropathy: Historical and contemporary considerations. Optom. Clin. 5 (1996) 77-112
99. Korhonen J.A., Gaspari M., and Falkenberg M. TWINKLE Has 5′→3′ DNA helicase activity and is specifically stimulated by mitochondrial single-stranded DNA-binding protein. J. Biol. Chem. 278 (2003) 48627-48632 Epub 2003 Sep 15
100. Koutnikova H., Campuzano V., Foury F., Dolle P., Cazzalini O., and Koenig M. Studies of human, mouse and yeast homologues indicate a mitochondrial function for frataxin. Nat. Genet. 16 (1997) 345-351
101. Kraytsberg Y., Kudryavtseva E., McKee A.C., Geula C., Kowall N.W., and Khrapko K. Mitochondrial DNA deletions are abundant and cause functional impairment in aged human substantia nigra neurons. Nat. Genet. 38 (2006) 518-520
102. Kujoth G.C., Hiona A., Pugh T.D., Someya S., Panzer K., Wohlgemuth S.E., Hofer T., Seo A.Y., Sullivan R., Jobling W.A., Morrow J.D., Van Remmen H., et al. Mitochondrial DNA mutations, oxidative stress, and apoptosis in mammalian aging. Science 309 (2005) 481-484
103. Langston J.W., Ballard P., Tetrud J.W., and Irwin I. Chronic parkinsonism in humans due to a product of meperidine-analog synthesis. Science 219 (1983) 979-980
104. Leigh D. Subacute necrotizing encephalomyelopathy in an infant. J. Neurol. Neurosurg. Psychiatry 14 (1951) 216-221
105. Lightowlers R.N., Chinnery P.F., Turnbull D.M., and Howell N. Mammalian mitochondrial genetics: Heredity, heteroplasmy and disease. Trends Genet. 13 (1997) 450-455
106. Liolitsa D., Rahman S., Benton S., Carr L.J., and Hanna M.G. Is the mitochondrial complex I ND5 gene a hot-spot for MELAS causing mutations?. Ann. Neurol. 53 (2003) 128-132
107. Lister R., Hulett J.M., Lithgow T., and Whelan J. Protein import into mitochondria: Origins and functions today (review). Mol. Membr. Biol. 22 (2005) 87-100
108. Lodi R., Cooper J.M., Bradley J.L., Manners D., Styles P., Taylor D.J., and Schapira A.H. Deficit of in vivo mitochondrial ATP production in patients with Friedreich ataxia. Proc. Natl. Acad. Sci. USA 96 (1999) 11492-11495
109. Loeffen J.L., Smeitink J.A., Trijbels J.M., Janssen A.J., Triepels R.H., Sengers R.C., and van den Heuvel L.P. Isolated complex I deficiency in children: Clinical, biochemical and genetic aspects. Hum. Mutat. 15 (2000) 123-134
110. Longley M.J., Clark S., Yu Wai Man C., Hudson G., Durham S.E., Taylor R.W., Nightingale S., Turnbull D.M., Copeland W.C., and Chinnery P.F. Mutant POLG2 disrupts DNA polymerase gamma subunits and causes progressive external ophthalmoplegia. Am. J. Hum. Genet. 78 (2006) 1026-1034 Epub 2006 May 4
111. Lutsenko S., and Cooper M.J. Localization of the Wilson's disease protein product to mitochondria. Proc. Natl. Acad. Sci. USA 95 (1998) 6004-6009
112. Mackey D.A., and Buttery R.G. Leber hereditary optic neuropathy in Australia. Aust. NZ. J. Ophthalmol. 20 (1992) 177-184
113. Majamaa K., Moilanen J.S., Uimonen S., Remes A.M., Salmela P.I., Karppa M., Majamaa-Volti K.A.M., Rusanen H., Sorri M., Peuhkurinen K.J., and Hassinen I.E. Epidemiology of A3243G, the mutation for mitochondrial encephalomyopathy, lactic acidosis, and strokelike episodes: Prevalence of the mutation in an adult population. Am. J. Hum. Genet. 63 (1998) 447-454
114. Man P.Y., Griffiths P.G., Brown D.T., Howell N., Turnbull D.M., and Chinnery P.F. The epidemiology of Leber hereditary optic neuropathy in the North East of England. Am. J. Hum. Genet. 72 (2003) 333-339
115. Mandel H., Szargel R., Labay V., Elpeleg O., Saada A., Shalata A., Anbinder Y., Berkowitz D., Hartman C., Barak M., Eriksson S., and Cohen N. The deoxyguanosine kinase gene is mutated in individuals with depleted hepatocerebral mitochondrial DNA. Nat. Genet. 29 (2001) 337-341
116. Margineantu D.H., Gregory Cox W., Sundell L., Sherwood S.W., Beechem J.M., and Capaldi R.A. Cell cycle dependent morphology changes and associated mitochondrial DNA redistribution in mitochondria of human cell lines. Mitochondrion 1 (2002) 425-435
117. Margulis L. Genetic and evolutionary consequences of symbiosis. Exp. Parasitol. 39 (1976) 277-349
118. Martinuzzi A., Bartolomei L., Carrozzo R., Mostacciuolo M., Carbonin C., Toso V., Ciafaloni E., Shanske S., DiMauro S., and Angelini C. Correlation between clinical and molecular features in two MELAS families. J. Neurol. Sci. 113 (1992) 222-229
119. Matthes M., Weisbeek P.J., and Denhardt D.T. Mechanism of replication of bacteriophage phi X174 XIX. Initiation of phi X174 viral strand DNA synthesis at internal sites on the genome. J. Virol. 42 (1982) 301-305
120. McFarland R., Clark K.M., Morris A.A., Taylor R.W., Macphail S., Lightowlers R.N., and Turnbull D.M. Multiple neonatal deaths due to a homoplasmic mitochondrial DNA mutation. Nat. Genet. 30 (2002) 145-146
121. McFarland R., Taylor R.W., and Turnbull D.M. The neurology of mitochondrial DNA disease. Lancet Neurol. 1 (2002) 343-351
122. McFarland R., Kirby D.M., Fowler K.J., Ohtake A., Ryan M.T., Amor D.J., Fletcher J.M., Dixon J.W., Collins F.A., Turnbull D.M., Taylor R.W., and Thorburn D.R. De novo mutations in the mitochondrial ND3 gene as a cause of infantile mitochondrial encephalopathy and complex I deficiency. Ann. Neurol. 55 (2004) 58-64
123. McFarland R., Schaefer A.M., Gardner J.L., Lynn S., Hayes C.M., Barron M.J., Walker M., Chinnery P.F., Taylor R.W., and Turnbull D.M. Familial myopathy: New insights into the T14709C mitochondrial tRNA mutation. Ann. Neurol. 55 (2004) 478-484
124. McFarland R., Taylor R.W., Chinnery P.F., Howell N., and Turnbull D.M. A novel sporadic mutation in cytochrome c oxidase subunit II as a cause of rhabdomyolysis. Neuromuscul. Disord. 14 (2004) 162-166
125. McNaught K.S., Olanow C.W., Halliwell B., Isacson O., and Jenner P. Failure of the ubiquitin-proteasome system in Parkinson's disease. Nat. Rev. Neurosci. 2 (2001) 589-594
126. Meirelles F., and Smith L.C. Mitochondrial genotype segregation in a mouse heteroplasmic lineage produced by embyonic karyoplast transplantation. Genetics 145 (1997) 445-451
127. Miller C., Saada A., Shaul N., Shabtai N., Ben-Shalom E., Shaag A., Hershkovitz E., and Elpeleg O. Defective mitochondrial translation caused by a ribosomal protein (MRPS16) mutation. Ann. Neurol. 56 (2004) 734-738
128. MITOMAP. A human mitochondrial genome database (2005). http://www.mitomap.org
129. MITOMAP. A human mitochondrial genome database (2006). http://www.mitomap.org
130. Montoya J., Ojala D., and Attardi G. Distinctive features of the 5′-terminal sequences of the human mitochondrial mRNAs. Nature 290 (1981) 465-470
131. Montoya J., Christianson T., Levens D., Rabinowitz M., and Attardi G. Identification of initiation sites for heavy-strand and light-strand transcription in human mitochondrial DNA. Proc. Natl. Acad. Sci. USA 79 (1982) 7195-7199
132. Moraes C.T., DiMauro S., Zeviani M., Lombes A., Shanske S., Miranda A.F., Nakase H., Bonilla E., Werneck L.C., Servidei S., Nonaka I., Koga Y., et al. Mitochondrial DNA deletions in progressive external ophthalmoplegia and Kearns-Sayre syndrome. N. Engl. J. Med. 320 (1989) 1293-1299
133. Morikawa Y., Matsuura N., Kakudo K., Higuchi R., Koike M., and Kobayashi Y. Pearson's marrow/pancreas syndrome: A histological and genetic study. Virchows Arch. A Pathol. Anat. Histopathol. 423 (1993) 227-231
134. LeuUUR in patients with the MELAS phenotype. Hum. Mol. Genet. 4 (1995) 1689-1691
135. Naviaux R.K., and Nguyen K.V. POLG mutations associated with Alpers' syndrome and mitochondrial DNA depletion. Ann. Neurol. 55 (2004) 706-712
136. Nishino I., Spinazzola A., and Hirano M. Thymidine phosphorylase gene mutations in MNGIE, a human mitochondrial disorder. Science 283 (1999) 689-692
137. Obermaier-Kusser B., Paetzke-Brunner I., Enter C., Muller-Hocker J., Zierz S., Ruitenbeek W., and Gerbitz K.D. Respiratory chain activity in tissues from patients (MELAS) with a point mutation of the mitochondrial genome [tRNA(Leu(UUR))]. FEBS Lett. 286 (1991) 67-70
138. Ojala D., Montoya J., and Attardi G. tRNA punctuation model of RNA processing in human mitochondria. Nature 290 (1981) 470-474
139. Oldfors A., Holme E., Tulinius M., and Larsson N.G. Tissue distribution and disease manifestations of the tRNA(Lys) A→G(8344) mitochondrial DNA mutation in a case of myoclonus epilepsy and ragged red fibres. Acta Neuropathol. 90 (1995) 328-333
140. Ozawa T. Mechanism of somatic mitochondrial DNA mutations associated with age and diseases. Biochim. Biophys. Acta 1271 (1995) 177-189
141. 2, a human COX assembly gene. Nat. Genet. 23 (1999) 333-337
142. Parisi M.A., and Clayton D.A. Similarity of human mitochondrial transcription factor 1 to high mobility group proteins. Science 252 (1991) 965-969
143. Park H., Davidson E., and King M.P. The pathogenic A3243G mutation in human mitochondrial tRNALeu(UUR) decreases the efficiency of aminoacylation. Biochemistry 42 (2003) 958-964
144. Polyak K., Li Y., Zhu H., Lengauer C., Willson J.K., Markowitz S.D., Trush M.A., Kinzler K.W., and Vogelstein B. Somatic mutations of the mitochondrial genome in human colorectal tumours. Nat. Genet. 20 (1998) 291-293
145. Poulton J., Morten K.J., Marchington D., Weber K., Brown G.K., Rotig A., and Bindoff L. Duplications of mitochondrial DNA in Kearns-Sayre syndrome. Muscle Nerve 3 (1995) S154-S158
146. Poulton J., Macaulay V., and Marchington D.R. Mitochondrial genetics '98: Is the bottleneck cracked?. Am. J. Hum. Genet. 62 (1998) 752-757
147. Poulton J., Luan J., Macaulay V., Hennings S., Mitchell J., and Wareham N.J. Type 2 diabetes is associated with a common mitochondrial variant: Evidence from a population-based case-control study. Hum. Mol. Genet. 11 (2002) 1581-1583
148. Prezant T.R., Agapian J.V., Bohlman M.C., Bu X., Oztas S., Qiu W.Q., Arnos K.S., Cortopassi G.A., Jaber L., Rotter J.I., Shohat M., and Fischel-Ghodsian N. Mitochondrial ribosomal RNA mutation associated with both antibiotic-induced and non-syndromic deafness. Nat. Genet. 4 (1993) 289-294
149. Pyle A., Foltynie T., Tiangyou W., Lambert C., Keers S.M., Allcock L.M., Davison J., Lewis S.J., Perry R.H., Barker R., Burn D.J., and Chinnery P.F. Mitochondrial DNA haplogroup cluster UKJT reduces the risk of PD. Ann. Neurol. 57 (2005) 564-567
150. Rahman S., Blok R.B., Dahl H.H., Danks D.M., Kirby D.M., Chow C.W., Christodoulou J., and Thorburn D.R. Leigh syndrome: Clinical features and biochemical and DNA abnormalities. Ann. Neurol. 39 (1996) 343-351
151. Reid F.M., Vernham G.A., and Jacobs H.T. A novel mitochondrial point mutation in a maternal pedigree with sensorineural deafness. Hum. Mutat. 3 (1994) 243-247
152. Rigoli L., Prisco F., Caruso R.A., Iafusco D., Ursomanno G., Zuccarello D., Ingenito N., Rigoli M., and Barberi I. Association of the T14709C mutation of mitochondrial DNA with maternally inherited diabetes mellitus and/or deafness in an Italian family. Diabet. Med. 18 (2001) 334-336
153. Ross O.A., McCormack R., Maxwell L.D., Duguid R.A., Quinn D.J., Barnett Y.A., Rea I.M., El-Agnaf O.M., Gibson J.M., Wallace A., Middleton D., and Curran M.D. mt4216C variant in linkage with the mtDNA TJ cluster may confer a susceptibility to mitochondrial dysfunction resulting in an increased risk of Parkinson's disease in the Irish. Exp. Gerontol. 38 (2003) 397-405
154. Saada A., Shaag A., Mandel H., Nevo Y., Eriksson S., and Elpeleg O. Mutant mitochondrial thymidine kinase in mitochondrial DNA depletion myopathy. Nat. Genet. 29 (2001) 342
155. Saker P.J., Hattersley A.T., Barrow B., Hammersley M.S., Horton V., Gillmer M.D., and Turner R.C. UKPDS 21: Low prevalence of the mitochondrial transfer RNA gene (tRNA(Leu(UUR))) mutation at position 3243bp in UK Caucasian type 2 diabetic patients. Diabet. Med. 14 (1997) 42-45
156. Santorelli F.M., Tessa A., D'Amati G., and Casali C. The emerging concept of mitochondrial cardiomyopathies. Am. Heart J. 141 (2001) E1
157. Sato A., Nakada K., Akimoto M., Ishikawa K., Ono T., Shitara H., Yonekawa H., and Hayashi J. Rare creation of recombinant mtDNA haplotypes in mammalian tissues. Proc. Natl. Acad. Sci. USA 102 (2005) 6057-6062 Epub 2005 Apr 13
158. Saunier P., Chretien D., Wood C., Rotig A., Bonnefont J.P., Saudubray J.M., Rabier D., Munnich A., and Rustin P. Cytochrome c oxidase deficiency presenting as recurrent neonatal myoglobinuria. Neuromuscul. Disord. 5 (1995) 285-289
159. Schaefer A.M., Taylor R.W., Turnbull D.M., and Chinnery P.F. The epidemiology of mitochondrial disorders-past, present and future. Biochim. Biophys. Acta 1659 (2004) 115-120
160. Schon E.A., Koga Y., Davidson M., Moraes C.T., and King M.P. The mitochondrial tRNA(Leu)(UUR)) mutation in MELAS: A model for pathogenesis. Biochim. Biophys. Acta 1101 (1992) 206-209
161. Schwartz M., and Vissing J. Paternal inheritance of mitochondrial DNA. N. Engl. J. Med. 347 (2002) 576-580
162. Shoffner J.M., Lott M.T., Lezza A.M., Seibel P., Ballinger S.W., and Wallace D.C. Myoclonic epilepsy and ragged-red fiber disease (MERRF) is associated with a mitochondrial DNA tRNA(Lys) mutation. Cell 61 (1990) 931-937
163. Shoubridge E.A. The ABCs of mitochondrial transcription. Nat. Genet. 31 (2002) 227-228
164. Silvestri G., Ciafaloni E., Santorelli F.M., Shanske S., Servidei S., Graf W.D., Sumi M., and DiMauro S. Clinical features associated with the A→G transition at nucleotide 8344 of mtDNA ("MERRF mutation"). Neurology 43 (1993) 1200-1206
165. Sissler M., Helm M., Frugier M., Giege R., and Florentz C. Aminoacylation properties of pathology-related human mitochondrial tRNA(Lys) variants. RNA 10 (2004) 841-853
166. Spelbrink J.N., Li F.Y., Tiranti V., Nikali K., Yuan Q.P., Wanrooij S., Garrido N., Comi G.P., Morandi L., Santoro L., Toscano A., Fabrizi G.M., et al. Human mitochondrial DNA deletions associated with mutations in the gene encoding Twinkle, a phage T7 gene 4-like protein localised in mitochondria. Nat. Genet. 28 (2001) 223-231
167. Spinazzola A., Marti R., Nishino I., Andreu A.L., Naini A., Tadesse S., Pela I., Zammarchi E., Donati M.A., Oliver J.A., and Hirano M. Altered thymidine metabolism due to defects of thymidine phosphorylase. J. Biol. Chem. 277 (2002) 4128-4133
168. Spinazzola A., Carrara F., Mora M., and Zeviani M. Mitochondrial myopathy and ophthalmoplegia in a sporadic patient with the 5698G→A mitochondrial DNA mutation. Neuromuscul. Disord. 14 (2004) 815-817
169. Spinazzola A., Viscomi C., Fernandez-Vizarra E., Carrara F., D'Adamo P., Calvo S., Marsano R.M., Donnini C., Weiher H., Strisciuglio P., Parini R., Sarzi E., et al. MPV17 encodes an inner mitochondrial membrane protein and is mutated in infantile hepatic mitochondrial DNA depletion. Nat. Genet. 38 (2006) 570-575
170. Sternberg D., Chatzoglou E., Laforet P., Fayet G., Jardel C., Blondy P., Fardeau M., Amselem S., Eymard B., and Lombes A. Mitochondrial DNA transfer RNA gene sequence variations in patients with mitochondrial disorders. Brain 124 (2001) 984-994
171. Steuerwald N., Barritt J.A., Adler R., Malter H., Schimmel T., Cohen J., and Brenner C.A. Quantification of mtDNA in single oocytes, polar bodies and subcellular components by real-time rapid cycle fluorescence monitored PCR. Zygote 8 (2000) 209-215
172. Stone E.M., Newman N.J., Miller N.R., Johns D.R., Lott M.T., and Wallace D.C. Visual recovery in patients with Leber's hereditary optic neuropathy and the 11778 mutation. J. Clin. Neuroophthalmol. 12 (1992) 10-14
173. Sue C.M., Tanji K., Hadjigeorgiou G., Andreu A.L., Nishino I., Krishna S., Bruno C., Hirano M., Shanske S., Bonilla E., Fischel-Ghodsian N., DiMauro S., et al. Maternally inherited hearing loss in a large kindred with a novel T7511C mutation in the mitochondrial DNA tRNA(Ser(UCN)) gene. Neurology 52 (1999) 1905-1908
174. Swerdlow R.H., Parks J.K., Miller S.W., Tuttle J.B., Trimmer P.A., Sheehan J.P., Bennett Jr. J.P., Davis R.E., and Parker Jr. W.D. Origin and functional consequences of the complex I defect in Parkinson's disease. Ann. Neurol. 40 (1996) 663-671
175. Taylor R.W., and Turnbull D.M. Mitochondrial DNA mutations in human disease. Nat. Rev. Genet. 6 (2005) 389-402
176. Taylor R.W., Barron M.J., Borthwick G.M., Gospel A., Chinnery P.F., Samuels D.C., Taylor G.A., Plusa S.M., Needham S.J., Greaves L.C., Kirkwood T.B., and Turnbull D.M. Mitochondrial DNA mutations in human colonic crypt stem cells. J. Clin. Invest. 112 (2003) 1351-1360
177. Taylor R.W., Giordano C., Davidson M.M., d'Amati G., Bain H., Hayes C.M., Leonard H., Barron M.J., Casali C., Santorelli F.M., Hirano M., Lightowlers R.N., et al. A homoplasmic mitochondrial transfer ribonucleic acid mutation as a cause of maternally inherited hypertrophic cardiomyopathy. J. Am. Coll. Cardiol. 41 (2003) 1786-1796
178. Taylor R.W., Schaefer A.M., Barron M.J., McFarland R., and Turnbull D.M. The diagnosis of mitochondrial muscle disease. Neuromuscul. Disord. 14 (2004) 237-245
179. Thyagarajan D., Shanske S., Vazquez-Memije M., De Vivo D., and DiMauro S. A novel mitochondrial ATPase 6 point mutation in familial bilateral striatal necrosis. Ann. Neurol. 38 (1995) 468-472
180. Tiranti V., Chariot P., Carella F., Toscano A., Soliveri P., Girlanda P., Carrara F., Fratta G.M., Reid F.M., Mariotti C., and Zeviani M. Maternally inherited hearing loss, ataxia and myoclonus associated with a novel point mutation in mitochondrial tRNASer(UCN) gene. Hum. Mol. Genet. 4 (1995) 1421-1427
181. Tiranti V., Hoertnagel K., Carrozzo R., Galimberti C., Munaro M., Granatiero M., Zelante L., Gasparini P., Marzella R., Rocchi M., Bayona-Bafluy M.P., Enriquez J.-A., et al. Mutations of SURF-1 in Leigh disease associated with cytochrome c oxidase deficiency. Am. J. Hum. Genet. 63 (1998) 1609-1621
182. Toompuu M., Yasukawa T., Suzuki T., Hakkinen T., Spelbrink J.N., Watanabe K., and Jacobs H.T. The 7472insC mitochondrial DNA mutation impairs the synthesis and extent of aminoacylation of tRNASer(UCN) but not its structure or rate of turnover. J. Biol. Chem. 277 (2002) 22240-22250
183. Traff J., Holme E., Ekbom K., and Nilsson B.Y. Ekbom's syndrome of photomyoclonus, cerebellar ataxia and cervical lipoma is associated with the tRNA(Lys) A8344G mutation in mitochondrial DNA. Acta Neurol. Scand. 92 (1995) 394-397
184. Triepels R.H., van den Heuvel L., Trijbels F., and Smeitink J.A. Respiratory chain complex I deficiency. Am. J. Med. Genet. 106 (2001) 37-45
185. Trifunovic A., Wredenberg A., Falkenberg M., Spelbrink J.N., Rovio A.T., Bruder C.E., Bohlooly Y.M., Gidlof S., Oldfors A., Wibom R., Tornell J., Jacobs H.T., et al. Premature ageing in mice expressing defective mitochondrial DNA polymerase. Nature 429 (2004) 417-423
186. Twelves D., Perkins K.S., and Counsell C. Systematic review of incidence studies of Parkinson's disease. Mov. Disord. 18 (2003) 19-31
187. Uusimaa J., Remes A.M., Rantala H., Vianionpaa L., Herva R., Vuopala K., Nuutinen M., Majamaa K., and Hassinen I.E. Childhood encepahlopathies and myopathies: A prospective study in a defined population to assess the frequency of mitochondrial diseases. Pediatrics 105 (2000) 598-603
188. Valente E.M., Abou-Sleiman P.M., Caputo V., Muqit M.M., Harvey K., Gispert S., Ali Z., Del Turco D., Bentivoglio A.R., Healy D.G., Albanese A., Nussbaum R., et al. Hereditary early-onset Parkinson's disease caused by mutations in PINK1. Science 304 (2004) 1158-1160
189. van Den Bosch B.J., de Coo R.F., Scholte H.R., Nijland J.G., van Den Bogaard R., deVisser M., de Die-Smulders C.E., and Smeets H.J. Mutation analysis of the entire mitochondrial genome using denaturing high performance liquid chromatography. Nucleic Acids Res. 28 (2000) E89
190. van den Ouweland J.M., Lemkes H.H., Ruitenbeek W., Sandkuijl L.A., de Vijlder M.F., Struyvenberg P.A., van de Kamp J.J., and Maassen J.A. Mutation in mitochondrial tRNA(Leu)(UUR) gene in a large pedigree with maternally transmitted type II diabetes mellitus and deafness. Nat. Genet. 1 (1992) 368-371
191. van der Walt J.M., Nicodemus K.K., Martin E.R., Scott W.K., Nance M.A., Watts R.L., Hubble J.P., Haines J.L., Koller W.C., Lyons K., Pahwa R., Stern M.B., et al. Mitochondrial polymorphisms significantly reduce the risk of Parkinson disease. Am. J. Hum. Genet. 72 (2003) 804-811
192. van der Walt J.M., Dementieva Y.A., Martin E.R., Scott W.K., Nicodemus K.K., Kroner C.C., Welsh-Bohmer K.A., Saunders A.M., Roses A.D., Small G.W., Schmechel D.E., Murali Doraiswamy P., et al. Analysis of European mitochondrial haplogroups with Alzheimer disease risk. Neurosci. Lett. 365 (2004) 28-32
193. Van Goethem G., Dermaut B., Lofgren A., Martin J.J., and Van Broeckhoven C. Mutation of POLG is associated with progressive external ophthalmoplegia characterized by mtDNA deletions. Nat. Genet. 28 (2001) 211-212
194. Van Goethem G., Martin J.J., Dermaut B., Lofgren A., Wibail A., Ververken D., Tack P., Dehaene I., Van Zandijcke M., Moonen M., Ceuterick C., De Jonghe P., et al. Recessive POLG mutations presenting with sensory and ataxic neuropathy in compound heterozygote patients with progressive external ophthalmoplegia. Neuromuscul. Disord. 13 (2003) 133-142
195. Van Goethem G., Luoma P., Rantamaki M., Al Memar A., Kaakkola S., Hackman P., Krahe R., Lofgren A., Martin J.J., De Jonghe P., Suomalainen A., Udd B., et al. POLG mutations in neurodegenerative disorders with ataxia but no muscle involvement. Neurology 63 (2004) 1251-1257
196. Vives-Bauza C., Andreu A.L., Manfredi G., Beal M.F., Janetzky B., Gruenewald T.H., and Lin M.T. Sequence analysis of the entire mitochondrial genome in Parkinson's disease. Biochem. Biophys. Res. Commun. 290 (2002) 1593-1601
197. Wallace D.C., Singh G., Lott M.T., Hodge J.A., Schurr T.G., Lezza A.M., Elsas II L.J., and Nikoskelainen E.K. Mitochondrial DNA mutation associated with Leber's hereditary optic neuropathy. Science 242 (1988) 1427-1430
198. Wilson F.H., Hariri A., Farhi A., Zhao H., Petersen K.F., Toka H.R., Nelson-Williams C., Raja K.M., Kashgarian M., Shulman G.I., Scheinman S.J., and Lifton R.P. A cluster of metabolic defects caused by mutation in a mitochondrial tRNA. Science 306 (2004) 1190-1194
199. Wong V.A., Beckingsale P.S., Oley C.A., and Sullivan T.J. Management of myogenic ptosis. Ophthalmology 109 (2002) 1023-1031
200. Yang M.Y., Bowmaker M., Reyes A., Vergani L., Angeli P., Gringeri E., Jacobs H.T., and Holt I.J. Biased incorporation of ribonucleotides on the mitochondrial L-strand accounts for apparent strand-asymmetric DNA replication. Cell 111 (2002) 495-505
201. Zeviani M., Moraes C.T., DiMauro S., Nakase H., Bonilla E., Schon E.A., and Rowland L.P. Deletions of mitochondrial DNA in Kearns-Sayre syndrome. Neurology 38 (1988) 1339-1346
202. Zeviani M., Sevidei S., Gallera C., Bertini E., DiMauro S., and DiDonato S. An autosomal dominant disorder with multiple deletions of mitochondrial DNA starting in the D-loop region. Nature 339 (1989) 309-311
203. Zeviani M., Bresolin N., Gellera C., Bordoni A., Pannacci M., Amati P., Moggio M., Servidei S., Scarlato G., and DiDonato S. Nucleus-driven multiple large-scale deletions of the human mitochondrial genome: A new autosomal dominant disease. Am. J. Hum. Genet. 47 (1990) 904-914
204. Zhu Z., Yao J., Johns T., Fu K., De Bie I., Macmillan C., Cuthbert A.P., Newbold R.F., Wang J., Chevrette M., Brown G.K., Brown R.M., et al. SURF1, encoding a factor involved in the biogenesis of cytochrome c oxidase, is mutated in Leigh syndrome. Nat. Genet. 20 (1998) 337-343
205. Zsurka G., Kraytsberg Y., Kudina T., Kornblum C., Elger C.E., Khrapko K., and Kunz W.S. Recombination of mitochondrial DNA in skeletal muscle of individuals with multiple mitochondrial DNA heteroplasmy. Nat. Genet. 37 (2005) 873-877 Epub 2005 Jul 17
206. Zupanc M.L., Moraes C.T., Shanske S., Langman C.B., Ciafaloni E., and DiMauro S. Deletion of mitochondrial DNA in patients with combined features of Kearns-Sayre and MELAS syndromes. Ann. Neurol. 29 (1991) 680-683